SQN Investors’s GoodRx Holdings GDRX Stock Holding History

SQN Investors’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-140,500	Closed	-$1.1M	–	8
2024 Q2	$1.1M	Buy	+140,500	New	+$1.04M	0.81%	20
2024 Q1	–	Sell	-1,277,895	Closed	-$8.56M	–	22
2023 Q4	$8.56M	Sell	1,277,895 -382,372	-23%	-$2.15M	5.36%	10
2023 Q3	$9.35M	Buy	+1,660,267	New	+$11.1M	5.41%	8

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SQN Investors's GDRX Position: Q3 2024 in Review

SQN Investors sold out of GoodRx Holdings (GDRX) in Q3 2024, closing a stake of 140,500 shares — an estimated $1.1M sold.

SQN Investors first reported a position in GDRX in Q3 2023 and held it in 3 quarters. The position peaked at $9.35M in Q3 2023. 168 funds tracked by Wall St. Rank hold GDRX as of Q3 2024.

SQN Investors reported no remaining GoodRx Holdings position as of Q3 2024 after selling out during the quarter.
SQN Investors sold 140,500 GoodRx Holdings shares in Q3 2024, an estimated $1.1M.
SQN Investors first reported a position in GoodRx Holdings in Q3 2023 and held it in 3 quarters.
SQN Investors's GoodRx Holdings position peaked at $9.35M in Q3 2023.
168 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2024.

Based on SQN Investors's 13F filing for Q3 2024.